OK, I just read the article provided by @07Gerard and it looks pretty sound to me. Just sloppy about "clinical work". The real point of the objections here is a few words earlier in the article - "the company is located in Australia, not in the United States". Just take out the next bit about clinical work being done down under and the quality improves greatly
Cell Therapy News/Articles, page-17525
-
- There are more pages in this discussion • 904 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.030(2.29%) |
Mkt cap ! $1.461B | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.35 | $1.28 | $1.677M | 1.289M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 44452 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 23596 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |